KEY TAKE AWAYS

• To define and measure global PET market in detail with respect to technology and application.
• To identify and analyze comprehensively the market structure with respect to the factors influencing the market growth and industry specific challenges.
• To strategically analyze markets with respect to their individual growth trends, future prospects and contribution to the total market
• To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia and Rest of the World)
• To strategically analyze and summarize the core competencies, product and service portfolio, recent developments and alliances of the market players in each of the sub-segments.
• To draw demand analysis to clearly analyze and benchmark the attributes and competitors from the end user’s perspective.

REPORT DESCRIPTION

There is significant increase in the global demand of the PET procedure in last three years which has boost the demand of the PET scanners and this trend is expected to continue in the near future. The advent of the PET CT and PET SPECT has further enhanced the functionality of the scanners for the radiologists, thus making the images easier to interpret in more user friendly format. The procedure volume increased significantly due to the PET scanner approval for diagnosis of lung cancer, breast imaging, and colon cancer. The market is significantly active towards technological innovations thereby limiting the scope of product differentiation. This compels the market participants to understand the competitive scenario to effectively meet the needs of the end users.

This market report will enable strategic understanding on the PET market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 50 market tables and about 40 company profiles. . The report will size all the sub markets and also give a detailed geographic split among the four major markets of North America, Europe, Asia and Rest of the World

MARKETS COVERED

The key markets covered in the report:

• PET market by technology (SPECT, PET/CT, hybrid technology - SPECT/CT)     
• PET market by application (Oncology, Cardiology, Neurology, Others)

• PET manufacturers
• PET suppliers and dealers
• Nuclear medicine  associations
• Research and strategic consulting firms

TABLE OF CONTENTS
 
1)  Global PET Market overview

 (PET procedure volume to exceed 2 million procedures by 2010. The emerging markets in diagnosing myocardial viability and early diagnosis of Alzheimer’s are expected to raise the market significantly)

   1.1. Market definition and evolution
   1.2. Supply side analysis and demand side analysis (methodology and process)
   1.3. Present and emerging market analysis (Market growth and relative share matrix)
   1.4. Market impact analysis: Impact of reducing price per unit and increased acceptance of technology
   1.5. Key findings
        1.5.1. Supply side analysis
        1.5.2. Demand side analysis 
   1.6. Competitive scenario: Siemens, Philips, GE leading the market
   1.7. Opportunity Analysis:
         - Market consolidation in U.S. and opportunities in emerging economies
         - Increasing unit shipments of PET mobile units.
   1.8. Emerging demands: Application in early diagnosis of Alzheimer’s disease and others
   1.9. Technology adoption analysis
   1.10. Geographical trends: U.S. leading the market, widening opportunities in Asia Pacific.
   1.11. Pricing analysis
   1.12. Strategic recommendations

SUPPLY SIDE ANALYSIS FOR PET MARKET

2. PET market segmentation by technology

(PET/CT remains the key technology earning the highest revenues. Multi-slice PET/CT with enhanced the functionality is demanded among the radiologist for as the images are easier to interpret. U.S. accounts for more than 65% of the total SPECT market. )

   2.1. Market overview
   2.2. Market Estimates (2009 to 2014) (By Technology and By Geography)
        2.2.1. Unit shipments
        2.2.2. Average price
        2.2.3. Market revenues
   2.3. Market Trends
        2.3.1. Market drivers
        2.3.2. Restraints
        2.3.3. Opportunities
   2.4. Gap analysis
   2.5. Market share and competitive landscape
   2.6. Strategic analysis
   2.7. PET segmentation (technology): (Each of the factors discussed above will be covered under the market segments discussed below)
        2.7.1. SPECT
        2.7.2. PET/CT
        2.7.3. Hybrid technology: SPECT/CT

3. PET market segmentation by application

(PET application in Oncology remains the highest with its share over 90%. However, escalating research in neurology is widening opportunities for PET market.)

        3.1.1. Market Overview
        3.1.2. Market Estimates (2009 to 2014) (By Application and By Geography)
               3.1.2.1. Unit shipments
               3.1.2.2. Market revenues
        3.1.3. Market Trends
               3.1.3.1. Market drivers
               3.1.3.2. Restraints
               3.1.3.3. Opportunities
        3.1.4. Gap analysis
        3.1.5. Market shares and competitive landscape
        3.1.6. End user analysis
        3.1.7. Strategic analysis
        3.1.8. Application market (Each of the factors discussed above will be covered under the market segments discussed below)
               3.1.8.1. Oncology
               3.1.8.2. Cardiology
               3.1.8.3. Neurology
               3.1.8.4. Others

DEMAND SIDE ANALYSIS

(Hospitals, healthcare providers, clinics etc will be contacted to track the below aspects)

   1.1. Buying criteria
        1.1.1. Price
        1.1.2. Image quality
        1.1.3. User friendliness
        1.1.4. Application capabilities
        1.1.5. Attributes impacting top line revenues
        1.1.6. Attributes impacting bottom line revenues
        1.1.7. Level of discounts
        1.1.8. Level of infrastructure available at healthcare provider’s facility
        1.1.9. Quality and durability
               1.1.10. Post sale services
               1.1.11. Budget allocation
               1.1.12. Competition level among healthcare providers
               1.1.13. Qualified resources
               1.1.14. Others
   1.2. Competitor benchmarking
        1.2.1. Competitive Benchmarking - Strategic
               1.2.1.1. Focus areas of the competitors in key segments
               1.2.1.2. Expansion- M&A, geographic, investments, patents
               1.2.1.3. Investing opportunities in new technologies
        1.2.2. Competitive Benchmarking – Commercially
               1.2.2.1. New Contracts signed  for past two years
               1.2.2.2. Pricing level and discounting policy
               1.2.2.3. Business models between product/ service provides and hospitals/ clinics
               1.2.2.4. Pricing policies (skimming price, competitive pricing etc)
        1.2.3. Competitive Benchmarking – Operational strength
               1.2.3.1. Distribution channel model and analysis
               1.2.3.2. Number of Employees
               1.2.3.3. Operating units
               1.2.3.4. Volume production
               1.2.3.5. Roadmap and expansion - commercial portfolio
        1.2.4. Competitive Benchmarking – Technical
               1.2.4.1. Image quality
               1.2.4.2. User friendliness
               1.2.4.3. Technology innovation cycle
               1.2.4.4. Durability
               1.2.4.5. Speedy performance
               1.2.4.6. Application capabilities
               1.2.4.7. Others

STRATEGIC CONCLUSIONS

   1.1. Key findings
   1.2. Gap Analysis  
   1.3. Competitive Analysis
   1.4. Geographic Analysis
        1.4.1. North America
        1.4.2. Europe
        1.4.3. Asia
        1.4.4. Rest of the world
   1.5. Patent Analysis

APPENDIX:

List of patents
Decision Support Data
Number of hospitals
Number of hospital beds
Population over 60
Number of skilled resources
Medical device budget allocation (average)
Volume procedures

Company profiles

1. GE Healthcare 
2. Philips Medical Systems
3. Siemens Medical 
4. Toshiba America Medical Systems 
5. Gamma Medica
6. Mallinckrodt 
7. Naviscan PET Systems 
8. TeraRecon 
9. CTI Molecular Imaging Inc. 
10. MedImage Inc. 
11. Positron Corporation

Positron Emission Tomography (PET) MARKET

Propelled by the favorable reimbursement policies, new emerging markets such as Alzheimer’s and continuing expanding oncology application segment, the global PET market is expected to reach around $2.2 billion by 2010. Reimbursement plays a major role in the adoption of any medical imaging technology particularly among the outpatient imaging centers and mobile PET scanners service providers, as the scope of overhead cost spread is not as conveniently as large hospitals.

In 2007 the reimbursement in the U.S. for the PET- CT was around $950 which was increased to $1,057 in 2008. The approval of PET scanning reimbursement in the U.S. by the Medicare and Medicaid for the Alzheimer’s disease widened the opportunities for the major market participants. Currently there are approximately 4.7 million Alzheimer’s patients in the U.S.  PET enables the radiologist to have the early diagnosis of the Alzheimer disease among the patients. Therefore this would further increase the demand of the PET scanners among the various health care centers.

Figure 1

PET APPLICATION MARKET SHARE IN PERCENTAGE

Source: Markets and Markets

Favorable reimbursements provided for the PET scanners would act as a catalyst in the growth of the market. Oncology continues to be the money spinning segment in the global PET application market.

>Figure 2

DEMAND FORECASTING BY THE TYPE OF THE BUYER

Source: Markets and Markets

KEY TRENDS

• Favorable reimbursement is boosting the demand of the PET scanners
• Emerging application in Alzheimer’s diagnosis is expected to drive the future market.
• Extended applications in Oncology market
• Technology innovation in PET-CT, SPECT-CT to focus on advanced diagnosis tools
• Wide acceptance of Hybrid technologies such as SPECT-CT
• The dominance of high priced multi-slice PET-CT’s
• Increased demand of SPECT from Non radiologist and Non -nuclear medicine Physicians

Owing to the increased R.O.I. provided by the PET-CT, SPECT, more and more Healthcare providers are expected to invest in Fixed PET-CT scanners in spite of using the services of a mobile PET- CT.

Please fill in the form below to receive a free copy of PDF Brochure.